tokens: The indications for switch were chronic CsA or Tac nephrotoxicity ( 12 ), acute CsA or Tac toxicity ( 3 ), severe facial dysmorphism ( 2 ), posttransplant lymphoproliferative disorder ( PTLD ) in remission ( 2 ), and hepatotoxicity in 1 .